North America Blood Glucose Monitoring System Market – Forecast (2019-2026) _ by Product (Self-Monitoring and Continuous Glucose Monitoring Systems), by Testing Site (Fingertip and Alternate Site Testing), by Patient Care Setting (Homecare and Hospital), by Application and by Geography


North America Blood Glucose Monitoring System Market size is expected to grow at a CAGR of 10.65% during the forecast period and the market size is expected to reach nearly US$ 4.33 Bn. by 2026.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

North America Blood Glucose Monitoring System Market

To know about the Research Methodology:-Request Free Sample Report

Blood glucose monitoring, in general, is a way of testing glucose concentration within blood, which in other words is known as glycemia. A blood glucose test is normally performed by piercing on the skin of the finger to draw blood which is applied over a chemically active test-strip. Manufacturers use different technologies for measurement, with most systems measuring electrical characteristic for determining glucose level present in the blood.

A blood glucose meter is required for monitoring the glucose level, which is a small and portable machine. It is also used for measuring the type of glucose and its presence within the blood and has recently become quite cost efficient and better availability as well. People having diabetes often use a blood glucose meter to receive real-time information about their health and also help them manage their condition accordingly.

Blood Glucose Monitoring System market for North America has been divided on the basis of product, testing type, patient care setting, application, and geography. Based on the product, the market has been segmented into self-monitoring and continuous monitoring systems. The self-monitoring systems accounted for the largest share with continuous monitoring growing at a high CAGR as compared to other segments.

Rising incidences of patients getting directly involved with their medical treatment along with the easy availability of real-time data have resulted in more number of people opting for self-monitoring devices. By testing type, the market for blood glucose monitoring system has been divided into fingertip and alternate site testing with fingertip holding a larger market share. The traditional way of ejecting blood has been through fingertips resulting in its dominance over other segments. The growing advances in the healthcare sector have resulted in people getting more aware of their body.

This trend has further led to the high demand for minimally invasive surgeries or treatments where people still prefer certain traditional medications leading to a higher market share of the fingertip. The market on the basis of patient care setting has been further segmented into homecare and hospitals. Homecare has come across as a dominant segment followed by hospitals. Cost efficiency, portability and growing awareness regarding continuous monitoring of diabetes’s have formed some important reasons that have driven overall growth. Diabetes 2 will hold the largest market share in the application segment.

North America has been focused on evolutions in the healthcare sector with pharmaceutical companies opting for cost-effective solutions that may help patients suffering from diabetes. The US and Canada have both been actively working on delivering cost-effective solutions for diabetes that is expected to dominate world health care in the next 20 years.

North America Blood Glucose Monitoring System Market ,Key Highlights:

• North America Blood Glucose Monitoring System market size analysis and forecast
• Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the North America Blood Glucose Monitoring System market
• Blood Glucose Monitoring System market segmentation on the basis of product, testing type, patient care setting, application, and geography.
• Blood Glucose Monitoring System market strategic analysis with respect to individual growth trends, future prospects along with a contribution of various sub-market stakeholders have been considered under the scope of a study
• Blood Glucose Monitoring System market analysis and forecast for major countries has been provided.
• Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies
• Competitive landscape of the key players operating in the Blood Glucose Monitoring System market including competitive developments, investments, and strategic expansion

North America Blood Glucose Monitoring System Market, Research Methodology:

The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the market value for North America Blood Glucose Monitoring System market.

Some of the key players of the North America Blood Glucose Monitoring System market include:

• Abbott Laboratories
• LifeScan
• Medtronic
• Dexcom
• Arkay, Inc.
• B. Braun Melsungen AG
• Bayer Healthcare AG
• Becton Dickinson
• F. Hoffmann-La Roche
• Novel Biomedical Corporation
• Terumo Europe NV
• Johnson & Johnson
• Terumo Medical Corporation
• Nipro Diagnostics, Inc
• Novo Nordisk
• Ypsomed AG
• GlySens Incorporated

North America Blood Glucose Monitoring System Market ,Key Target Audience:

• Blood glucose monitoring systems and related devices manufacturers
• Hospitals, diagnostic centers, homecare service providers, and medical colleges
• Teaching hospitals and academic medical centers
• Suppliers and distributors of blood glucose monitoring systems
• Government bodies or municipal corporations


Scope of the North America Blood Glucose Monitoring System Market Report: Inquire before buying

The research report segments North America Blood Glucose Monitoring System market based on product, testing site, patient care setting, application and geography.

North America Blood Glucose Monitoring System Market, By Product:

• Self-Monitoring Blood Glucose Systems
• Blood Glucose meters
• Testing strips
• Lancets & Lancing Devices

• Continuous Glucose Monitoring Systems
• Sensors
• Transmitters
• Receivers

North America Blood Glucose Monitoring System Market, By Testing Site:

• Fingertip testing
• Alternate Site Testing

North America Blood Glucose Monitoring System Market, By Patient Care Setting:

• Self/Home Care
• Hospital & Clinics

North America Blood Glucose Monitoring System Market, By Application:

• Type 2 Diabetes
• Type 1 Diabetes
• Gestational Diabetes

North America Blood Glucose Monitoring System Market, By Geography:

• North America
• US
• Canada

North America Blood Glucose Monitoring System Market Geographic Analysis

• Breakdown of US Blood Glucose Monitoring System market
• Breakdown of Canada Blood Glucose Monitoring System market

Available Customization

Maximize Market Research offers customization of reports according to the specific requirement of our clients. 





North America Blood Glucose Monitoring System Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: North America Blood Glucose Monitoring System Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
4.8. Patent Registration

5. Supply Side and Demand Side Indicators

6. North America Blood Glucose Monitoring System Market Analysis and Forecast

7. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Product
7.1. Introduction and Definition
7.2. Key Findings
7.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Product
7.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Product
7.5. North America Blood Glucose Monitoring System Market Analysis, by Product
7.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Product

8. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Testing Site
8.1. Introduction and Definition
8.2. Key Findings
8.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site
8.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Testing Site
8.5. North America Blood Glucose Monitoring System Market Analysis, by Testing Site
8.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site

9. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Patient Care Setting
9.1. Introduction and Definition
9.2. Key Findings
9.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting
9.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Patient Care Setting
9.5. North America Blood Glucose Monitoring System Market Analysis, by Patient Care Setting
9.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting

10. North America Blood Glucose Monitoring System Market Analysis and Forecast, by Application
10.1. Introduction and Definition
10.2. Key Findings
10.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Application
10.4. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Application
10.5. North America Blood Glucose Monitoring System Market Analysis, by Application
10.6. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Application

11. North America Blood Glucose Monitoring System Market Analysis, by Region
11.1. North America Blood Glucose Monitoring System Market Value Share Analysis, by Region
11.2. North America Blood Glucose Monitoring System Market Size (US$ Bn) Forecast, by Region
11.3. North America Blood Glucose Monitoring System Market Attractiveness Analysis, by Region

12. North America Blood Glucose Monitoring System Market Analysis
12.1. Key Findings
12.2. North America Blood Glucose Monitoring System Market Overview
12.3. North America Blood Glucose Monitoring System Market Value Share Analysis, by Product
12.4. North America Blood Glucose Monitoring System Market Forecast, by Product
12.4.1. Self-Monitoring Blood Glucose Systems
12.4.1.1. Blood Glucose meters
12.4.1.2. Testing strips
12.4.1.3. Lancets & Lancing Devices
12.4.2. Continuous Glucose Monitoring Systems
12.4.2.1. Sensors
12.4.2.2. Transmitters
12.4.2.3. Receivers
12.5. North America Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site
12.6. North America Blood Glucose Monitoring System Market Forecast, by Testing Site
12.6.1. Fingertip testing
12.6.2. Alternate Site Testing
12.7. North America Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting
12.8. North America Blood Glucose Monitoring System Market Forecast, by Patient Care Setting
12.8.1. Self/Home Care
12.8.2. Hospital & Clinics
12.9. North America Blood Glucose Monitoring System Market Value Share Analysis, by Application
12.10. North America Blood Glucose Monitoring System Market Forecast, by Application
12.10.1. Type 2 Diabetes
12.10.2. Type 1 Diabetes
12.10.3. Gestational Diabetes
12.11. North America Blood Glucose Monitoring System Market Value Share Analysis, by Country
12.12. North America Blood Glucose Monitoring System Market Forecast, by Country
12.12.1. U.S.
12.12.2. Canada
12.13. North America Blood Glucose Monitoring System Market Analysis, by Country
12.14. U.S. Blood Glucose Monitoring System Market Forecast, by Product
12.14.1. Self-Monitoring Blood Glucose Systems
12.14.1.1. Blood Glucose meters
12.14.1.2. Testing strips
12.14.1.3. Lancets & Lancing Devices
12.14.2. Continuous Glucose Monitoring Systems
12.14.2.1. Sensors
12.14.2.2. Transmitters
12.14.2.3. Receivers
12.15. U.S. Blood Glucose Monitoring System Market Forecast, by Testing Site
12.15.1. Fingertip testing
12.15.2. Alternate Site Testing
12.16. U.S. Blood Glucose Monitoring System Market Forecast, by Patient Care Setting
12.16.1. Self/Home Care
12.16.2. Hospital & Clinics
12.16.3.
12.17. U.S. Blood Glucose Monitoring System Market Forecast, by Application
12.17.1. Type 2 Diabetes
12.17.2. Type 1 Diabetes
12.17.3. Gestational Diabetes
12.18. Canada Blood Glucose Monitoring System Market Forecast, by Product
12.18.1. Self-Monitoring Blood Glucose Systems
12.18.1.1. Blood Glucose meters
12.18.1.2. Testing strips
12.18.1.3. Lancets & Lancing Devices
12.18.2. Continuous Glucose Monitoring Systems
12.18.2.1. Sensors
12.18.2.2. Transmitters
12.18.2.3. Receivers
12.19. Canada Blood Glucose Monitoring System Market Forecast, by Testing Site
12.19.1. Fingertip testing
12.19.2. Alternate Site Testing
12.20. Canada Blood Glucose Monitoring System Market Forecast, by Patient Care Setting
12.20.1. Self/Home Care
12.20.2. Hospital & Clinics
12.21. Canada Blood Glucose Monitoring System Market Forecast, by Application
12.21.1. Type 2 Diabetes
12.21.2. Type 1 Diabetes
12.21.3. Gestational Diabetes
12.22. North America Blood Glucose Monitoring System Market Attractiveness Analysis
12.22.1. By Product
12.22.2. By Testing Site
12.22.3. By Patient Care Setting
12.22.4. By Application
12.23. PEST Analysis
12.24. Key Trends
12.25. Key Developments

13. Company Profiles
13.1. Market Share Analysis, by Company
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Market Consolidation
13.2.3.1. M&A by Regions, Industry with Applications
13.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
13.3. Company Profiles: Key Players
13.3.1. Abbott Laboratories
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Business Strategy
13.3.1.5. Recent Developments
13.3.1.6. Developments Footprints
13.3.2. LifeScan
13.3.3. Medtronic
13.3.4. Dexcom
13.3.5. Arkay, Inc.
13.3.6. B. Braun Melsungen AG
13.3.7. Bayer Healthcare AG
13.3.8. Becton Dickinson
13.3.9. F. Hoffmann-La Roche
13.3.10. Novel Biomedical Corporation
13.3.11. Terumo Europe NV
13.3.12. Johnson & Johnson
13.3.13. Terumo Medical Corporation
13.3.14. Nipro Diagnostics, Inc
13.3.15. Novo Nordisk
13.3.16. Ypsomed AG
13.3.17. GlySens Incorporated

14. Primary Key Insights
  • INQUIRE BEFORE BUYING